Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Delavigne

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Medecine Et Maladies Infectieuses|December 18, 2018
[Refractory cutaneous leishmaniasis: Benefit of miltefosine]C Guerveno, K Delavigne, A Berry, et al.
Annals of Hematology|February 14, 2015
Acquired epidermodysplasia verruciformis, a new opportunistic infection related to bendamustineP Cougoul, E Tournier, K Delavigne, et al.
La Revue De Medecine Interne|August 26, 2011
[Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]G Moulis, K Delavigne, F Huguet, et al.
La Revue De Medecine Interne|December 15, 2010
[Chronic headaches]G Moulis, K Delavigne, M Alvarez, et al.
La Revue De Medecine Interne|May 6, 2019
[Management of myelodysplastic syndromes in 2019: An update]T Comont, K Delavigne, P Cougoul, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2010
Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndromeC Farah, C Bulai Livideanu, J Jegu, et al.
The British Journal of Dermatology|October 23, 2009
Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibodyI Marie, L Lahaxe, O Benveniste, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Medecine Et Maladies Infectieuses|December 18, 2018
[Refractory cutaneous leishmaniasis: Benefit of miltefosine]C Guerveno, K Delavigne, A Berry, et al.
Annals of Hematology|February 14, 2015
Acquired epidermodysplasia verruciformis, a new opportunistic infection related to bendamustineP Cougoul, E Tournier, K Delavigne, et al.
La Revue De Medecine Interne|August 26, 2011
[Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]G Moulis, K Delavigne, F Huguet, et al.
La Revue De Medecine Interne|December 15, 2010
[Chronic headaches]G Moulis, K Delavigne, M Alvarez, et al.
La Revue De Medecine Interne|May 6, 2019
[Management of myelodysplastic syndromes in 2019: An update]T Comont, K Delavigne, P Cougoul, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2010
Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndromeC Farah, C Bulai Livideanu, J Jegu, et al.
The British Journal of Dermatology|October 23, 2009
Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibodyI Marie, L Lahaxe, O Benveniste, et al.
Pageof 1